Gilead Sciences Stock Analysis (NASDAQ:GILD)

Add to My Stocks
$71.91 $1.16 (1.59%) GILD stock closing price Jan 17, 2017 (Closing)
Watch Robo Advisor Video of GILD Stock Analysis
Gilead Sciences
Updated on : Jan 17, 2017
previous close
GILD 71.9 (0%)
S&P 500 2267.9 (0%)
Closing Price On: Jan 17, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Biomed-Genetics
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
60.8%
Sector Average:
-1.3%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
27.26B
Debt/Equity Ratio:
 1.57
Compared to the industry
Cash Flow
Operating cash flow:
$4.33B
Net Income:
$3.33B
Dividend Yield
GILD dividend yield:
2.5%
PROS      CONS
Operating Margins
Net Margins
ROIC
ROE
FCF Margin
PE Valuation
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
GILD PS :
3
Industry PS :
4.5
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
51.9%
Return on Equity:
89.2%
Free Cash Flow Margin:
55.1%
Double Tap To Exit Full Screen
0:00
/

Gilead Sciences Analysis Video

6345 9 2

View Gilead Sciences stock analysis video. This is our GILD analyst opinion covering the buy and sell arguments for GILD stock.

Gilead Sciences, Inc. Stock Rating (4.2/5)

Our Gilead Sciences stock opinion is based on fundamentals of the company. This Gilead Sciences stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy GILD stock?

  • The TTM operating margin was good at 60.8% for Gilead Sciences.
  • Net margins came in at average 47.7% for Gilead Sciences over the last twelve months.
  • The price to earnings multiple of 6 is attractive when compared with the industry average PE ratio of 21.9.
  • The lower PS ratio 3 for GILD stock versus Medical-Biomed-Genetics industry average of 4.5 is a positive for the company.
  • Gilead Sciences's return on invested capital of 51.9% is good.
  • Gilead Sciences has a good Return On Equity (ROE) of 89.2%.
  • The company has a good Free Cash Flow (FCF) margin of 55.1%.

Should you sell GILD stock?

  • Gilead Sciences has a debt/equity ratio of  1.57, which is worse than the average in the Medical sector.

Comments on this video and Gilead Sciences stock